Elevated cytokine and chemokine levels in the placenta are associated with in-utero HIV-1 mother-to-child transmission
- PMID: 22301415
- PMCID: PMC3505685
- DOI: 10.1097/QAD.0b013e3283519b00
Elevated cytokine and chemokine levels in the placenta are associated with in-utero HIV-1 mother-to-child transmission
Abstract
Objective: To determine whether there is an association between cytokine and chemokine levels in plasma isolated from the placenta and HIV-1 mother-to-child transmission (MTCT).
Design: We designed a case-control study of HIV-infected, pregnant women enrolled in the Malaria and HIV in Pregnancy cohort. Participants were recruited in Blantyre, Malawi, from 2000 to 2004. Patients were women whose children were HIV-1 DNA-positive at birth (in-utero MTCT) or HIV-1 DNA-negative at birth and HIV-1 DNA-positive at 6 weeks postpartum (intrapartum MTCT); controls were women whose children were HIV-1 DNA-negative both at birth and 6 weeks postpartum.
Methods: After delivery, blood was isolated from an incision on the basal plate of the placenta. We used a Bio-Plex human cytokine assay (Bio-Rad, Hercules, California USA) to simultaneously quantify 27 cytokines, chemokines and growth factors in placental plasma. HIV-1 RNA copies were quantified with the Roche Amplicor kit.
Results: Levels of interleukin (IL) 4, IL-5, IL-6, IL-7, IL-9, eotaxin, IL-1Ra and interferon gamma-induced protein 10 (IP-10) were significantly elevated in placental plasma isolated from cases of in-utero HIV-1 MTCT. In contrast, only granulocyte colony-stimulating factor was elevated in placental plasma isolated from cases of intrapartum MTCT. After adjusting for maternal age, gestational age and peripheral CD4(+) T-cell count, every log(10) increase in placental IP-10 was associated with a three-fold increase in the prevalence of in-utero HIV-1 MTCT.
Conclusion: Elevated cytokine and chemokine levels in placental plasma were associated with in-utero and not intrapartum MTCT. IP-10, which is both a T-cell chemokine and potentiator of HIV-replication, was robustly and independently associated with prevalent, in-utero MTCT.
Figures

Similar articles
-
Maternal-fetal microtransfusions and HIV-1 mother-to-child transmission in Malawi.PLoS Med. 2006 Jan;3(1):e10. doi: 10.1371/journal.pmed.0030010. Epub 2005 Nov 22. PLoS Med. 2006. PMID: 16287342 Free PMC article.
-
Maternal syphilis infection is associated with increased risk of mother-to-child transmission of HIV in Malawi.AIDS. 2006 Sep 11;20(14):1869-77. doi: 10.1097/01.aids.0000244206.41500.27. AIDS. 2006. PMID: 16954728
-
Association of HIV and malaria with mother-to-child transmission, birth outcomes, and child mortality.J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):472-6. doi: 10.1097/QAI.0b013e318162afe0. J Acquir Immune Defic Syndr. 2008. PMID: 18332766
-
Factors responsible for mother to child transmission (MTCT) of HIV-1 - a review.Eur Rev Med Pharmacol Sci. 2017 Oct;21(4 Suppl):74-78. Eur Rev Med Pharmacol Sci. 2017. PMID: 29165760 Review.
-
Mother-to-child transmission of HIV-1: advances and controversies of the twentieth centuries.AIDS Rev. 2004 Apr-Jun;6(2):67-78. AIDS Rev. 2004. PMID: 15332429 Review.
Cited by
-
Anthropometry, body composition, early growth and chronic disease risk factors among Zambian adolescents exposed or not to perinatal maternal HIV.Br J Nutr. 2022 Jun 13;129(4):1-12. doi: 10.1017/S0007114522001775. Online ahead of print. Br J Nutr. 2022. PMID: 35695182 Free PMC article.
-
Severity of maternal HIV-1 disease is associated with adverse birth outcomes in Malawian women: a cohort study.J Acquir Immune Defic Syndr. 2013 Dec 1;64(4):392-9. doi: 10.1097/QAI.0b013e3182a2d13c. J Acquir Immune Defic Syndr. 2013. PMID: 23846560 Free PMC article.
-
Impact of HIV-1 infection on the feto-maternal crosstalk and consequences for pregnancy outcome and infant health.Semin Immunopathol. 2016 Nov;38(6):727-738. doi: 10.1007/s00281-016-0578-9. Epub 2016 Jul 8. Semin Immunopathol. 2016. PMID: 27392971 Review.
-
HIV, Cytomegalovirus, and Malaria Infections during Pregnancy Lead to Inflammation and Shifts in Memory B Cell Subsets in Kenyan Neonates.J Immunol. 2019 Mar 1;202(5):1465-1478. doi: 10.4049/jimmunol.1801024. Epub 2019 Jan 23. J Immunol. 2019. PMID: 30674575 Free PMC article.
-
Impact of maternal HIV infection on pregnancy outcomes in southwestern China - a hospital registry based study.Epidemiol Infect. 2019 Jan;147:e124. doi: 10.1017/S0950268818003345. Epidemiol Infect. 2019. PMID: 30868995 Free PMC article.
References
-
- De Cock KM, Fowler MG, Mercier E, de Vincenzi I, Saba J, Hoff E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA. 2000;283(9):1175–1182. - PubMed
-
- Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002;29(5):484–494. - PubMed
-
- John GC, Nduati RW, Mbori-Ngacha DA, Richardson BA, Panteleeff D, Mwatha A, et al. Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis. 2001;183(2):206–212. - PubMed
-
- Montano M, Russell M, Gilbert P, Thior I, Lockman S, Shapiro R, et al. Comparative prediction of perinatal human immunodeficiency virus type 1 transmission, using multiple virus load markers. J Infect Dis. 2003;188(3):406–413. - PubMed
-
- The European Collaborative Study: Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. AIDS. 1999;13(11):1377–1385. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials